ACM
GRTX

Altium Capital Management’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Altium Capital Management’s Portfolio GRTX Stock Details GRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-300,605
Closed -$2.44M – 164
2021
Q3 		$2.44M Buy
300,605
+80,705
+37% +$692K 0.64% 65
2021
Q2 		$2.16M Buy
+219,900
New +$1.79M 0.5% 79

Other funds holding GRTX

SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $121M AUM 56.89% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Altium Capital Management's GRTX Position: Q4 2021 in Review

Altium Capital Management sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q4 2021, closing a stake of 300,605 shares — an estimated $2.44M sold.

Altium Capital Management first reported a position in GRTX in Q2 2021 and held it in 2 quarters. The position peaked at $2.44M in Q3 2021. 44 funds tracked by Wall St. Rank hold GRTX as of Q4 2021.

  • Altium Capital Management reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Altium Capital Management sold 300,605 Galera Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $2.44M.
  • Altium Capital Management first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2021 and held it in 2 quarters.
  • Altium Capital Management's Galera Therapeutics, Inc. Common Stock position peaked at $2.44M in Q3 2021.
  • 44 funds tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Altium Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.